Results 71 to 80 of about 5,411 (177)

The Oxidative Stress Response Highly Depends on Glucose and Iron Availability in Aspergillus fumigatus

Journal of Fungi
Pathogens have to cope with oxidative, iron- and carbon(glucose)-limitation stresses in the human body. To understand how combined iron–carbon limitation alters oxidative stress responses, Aspergillus fumigatus was cultured in glucose–peptone or peptone ...
Tamás Emri, Károly Antal, Kinga Varga, Barnabás Csaba Gila, István Pócsi   +4 more
doaj   +1 more source

Monitoring long‐term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with β‐thalassaemia major: application of SQUID biomagnetic liver susceptometry [PDF]

, 2003
Roland A. Fischer, Filomena Longo, Peter Nielsen, Rainer Engelhardt, Robert C. Hider, Antonio Piga   +5 more
openalex   +1 more source

Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: a systematic review [PDF]

, 2002
J. Jaime, Krista F. Huybrechts, Traci C. Green   +2 more
openalex   +1 more source

Sex and Gender Differences in Iron Chelation

Biomedicines
Background/Objectives: In the absence of physiological mechanisms to excrete excessive iron, the administration of iron chelation therapy is necessary.
Sarah Allegra, Stefano Comità, Antonella Roetto, Silvia De Francia   +3 more
doaj   +1 more source

Deferiprone: new environmental perspectives. Insights into its sequestering ability vs. different metal cations

Ecotoxicology and Environmental Safety
Deferiprone, generally, is considered an important chelating agent for Fe3+ overload. From a literature data analysis, a lack of information on the interaction of this molecule toward a series of metal cations emerged, inducing to fill out the topic. The
Anna Irto, Francesco Crea, Marco Milone, Giuseppe Gattuso, Clemente Bretti, Concetta De Stefano, Rosalia Maria Cigala   +6 more
doaj   +1 more source

Iron mobilisation from transferrin by deferiprone (L1) [PDF]

, 2005
George J. Kontoghiorghes, Annita Kolnagou, Eleni Eracleous, Robert W. Evans   +3 more
openalex   +1 more source

Solubility of Deferiprone in Non-Aqueous Mixtures of Polyethylene Glycol 400 and 1-Propanol at 293.2–323.2 K

Liquids
Utilizing the shake-flask technique under atmospheric pressure (101 kPa) within the temperature range of 293.2 to 313.2 K, the experimental solubility and density values of deferiprone were determined in binary mixtures of polyethylene glycol 400 and 1 ...
Homa Rezaei, Abolghasem Jouyban
doaj   +1 more source

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy [PDF]

, 2013
Alessia Pepe, Antonella Meloni, Giuseppe Rossi, Liana Cuccia, Giuseppe D'Ascola, Michele Santodirocco, Paolo Cianciulli, Vincenzo Caruso, Maria Antonietta Romeo, Aldo Filosa, Lorella Pitrolo, Maria Caterina Putti, Angelo Peluso, Saveria Campisi, Massimiliano Missere, Massimo Midiri, L. Gulino, Vincenzo Positano, Massimo Lombardi, Paolo Ricchi   +19 more
openalex   +1 more source

Deferiprone and Gallium-Protoporphyrin Have the Capacity to Potentiate the Activity of Antibiotics in Staphylococcus aureus Small Colony Variants [PDF]

, 2017
Katharina Richter, Nicky Thomas, Guimin Zhang, Clive A. Prestidge, Tom Coenye, Peter‐John Wormald, Sarah Vreugde   +6 more
openalex   +1 more source

P1442: PRACTICE-BASED EVIDENCE: LONG-TERM SAFETY COHORT OF DEFERIPRONE IN PATIENTS WITH SICKLE CELL DISEASE FROM THE US REGISTRY

, 2023
Sherif M. Badawy, Alexis A. Thompson, Fernando Tricta, Noemi Toiber Temin, Caroline Fradette, Anna Rozova, Janet L. Kwiatkowski   +6 more
openalex   +1 more source